Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|19|6|977-1009
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.19, Iss.6, 2013-02, pp. : 977-1009
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Current Cancer Drug Targets, Vol. 9, Iss. 4, 2009-06 ,pp. :
Access to resources
Recommend
Mitochondrial Serine Protease HtrA2/Omi as a Potential Therapeutic Target
Current Drug Targets, Vol. 10, Iss. 4, 2009-04 ,pp. :
The serine protease HtrA1 is a novel prognostic factor for human mesothelioma
By Baldi Alfonso Mottolese Marcella Vincenzi Bruno Campioni Mara Mellone Pasquale Di Marino Mariapia di Crescenzo Vincenzo G Visca Paolo Menegozzo Simona Spugnini Enrico P Citro Gennaro Ceribelli Anna Mirri Alessandra Chien Jeremy Shridhar Viji Ehrmann Michael Santini Mario Facciolo Francesco
Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. :
Protease-Activated Receptors as Therapeutic Targets in Visceral Pain
Current Neuropharmacology, Vol. 11, Iss. 6, 2013-12 ,pp. :